Rheonova is proud to announce that the RheoCare project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 889360.
The aim is to implement an automated sample manipulation device on the Rheomuco.
Rheonova exploits sputum rheology as a biophysical marker of respiratory diseases.Rheonova strives to provide practitioners in care centres a unique and affordable rheometer, Rheomuco, which can be operated with no rheological background prerequisite, in order to monitor patients and forecast exacerbations.